Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Organic Chemistry
|
November 21, 2007
Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues
Wenlan Chen, Chengfeng Xia, Jinhua Wang, et al.
Chemmedchem
|
September 26, 2009
The roles of 3' and 4' hydroxy groups in alpha-galactosylceramide stimulation of invariant natural killer T cells
Chengfeng Xia, Wenpeng Zhang, Yalong Zhang, et al.
Journal of Medicinal Chemistry
|
February 3, 2006
Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance
Lanyan Fang, Guisheng Zhang, Chenglong Li, et al.
The Journal of Biological Chemistry
|
November 25, 2010
Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation
Kangdong Liu, Yong-Yeon Cho, Ke Yao, et al.
Free Radical Research
|
September 7, 2016
15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2
Jee-Eun Choi, Jung-Hyun Kim, Na-Young Song, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 3, 2011
(3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo
Dong Joon Kim, Kanamata Reddy, Myoung Ok Kim, et al.
Nature Structural & Molecular Biology
|
February 7, 2012
ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4
Myoung Ok Kim, Sung-Hyun Kim, Yong-Yeon Cho, et al.
Oncogene
|
June 16, 2018
Targeting PRPK and TOPK for skin cancer prevention and therapy
Eunmiri Roh, Mee-Hyun Lee, Tatyana A Zykova, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Targeting PRPK Function Blocks Colon Cancer Metastasis
Tatyana Zykova, Feng Zhu, Lei Wang, et al.
Carcinogenesis
|
September 11, 2012
Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B
Xiang Li, Haitao Li, Shengqing Li, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Organic Chemistry
|
November 21, 2007
Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues
Wenlan Chen, Chengfeng Xia, Jinhua Wang, et al.
Chemmedchem
|
September 26, 2009
The roles of 3' and 4' hydroxy groups in alpha-galactosylceramide stimulation of invariant natural killer T cells
Chengfeng Xia, Wenpeng Zhang, Yalong Zhang, et al.
Journal of Medicinal Chemistry
|
February 3, 2006
Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance
Lanyan Fang, Guisheng Zhang, Chenglong Li, et al.
The Journal of Biological Chemistry
|
November 25, 2010
Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation
Kangdong Liu, Yong-Yeon Cho, Ke Yao, et al.
Free Radical Research
|
September 7, 2016
15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2
Jee-Eun Choi, Jung-Hyun Kim, Na-Young Song, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
September 3, 2011
(3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo
Dong Joon Kim, Kanamata Reddy, Myoung Ok Kim, et al.
Nature Structural & Molecular Biology
|
February 7, 2012
ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4
Myoung Ok Kim, Sung-Hyun Kim, Yong-Yeon Cho, et al.
Oncogene
|
June 16, 2018
Targeting PRPK and TOPK for skin cancer prevention and therapy
Eunmiri Roh, Mee-Hyun Lee, Tatyana A Zykova, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Targeting PRPK Function Blocks Colon Cancer Metastasis
Tatyana Zykova, Feng Zhu, Lei Wang, et al.
Carcinogenesis
|
September 11, 2012
Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B
Xiang Li, Haitao Li, Shengqing Li, et al.
Page
of 2